My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Regulus Therapeutics Inc. - Common Stock (NQ:RGLS)

8.160 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Regulus Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

58 Stocks Moving In Thursday's Mid-Day Session ↗

May 12, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.

Via Benzinga

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More ↗

May 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For March 10, 2022 ↗

March 10, 2022

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...

Via Benzinga

28 Stocks Moving in Thursday's Pre-Market Session ↗

May 12, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 89.7% to $0.1480 in pre-market trading after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 11, 2022

Via Benzinga

Earnings Preview: Regulus Therapeutics ↗

May 11, 2022

Regulus Therapeutics (NASDAQ:RGLS) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

FDA Clears Regulus Therapeutics' IND for RGLS8429 In Autosomal Dominant Polycystic Kidney Disease (ADPKD) ↗

May 11, 2022

Regulus Therapeutics Inc. (NASDAQ: RGLS) announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) Application for RGLS8429 for the treatment of...

Via Benzinga

Earnings Scheduled For May 12, 2022 ↗

May 12, 2022

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.

Via Benzinga

99 Biggest Movers From Yesterday ↗

May 12, 2022

Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 11, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 04, 2022

During Wednesday's trading, 435 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 28, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 18, 2022

Gainers Rockwell Medical (NASDAQ:RMTI) stock rose 9.2% to $0.4 during Monday's after-market session. The company's market cap stands at $37.5 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 12, 2022

Gainers

Via Benzinga

Regulus Starts Preclinical Studies In ALS Under Pact With Brigham and Women's Hospital ↗

March 24, 2022

Regulus Therapeutics Inc (NASDAQ: RGLS) has

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 23, 2022

Gainers Creative Medical Tech (NASDAQ:CELZ) shares rose 78.8% to $3.04 during Wednesday's pre-market session. The market value of their outstanding shares is at $19.2...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 21, 2022

Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 25.3% to $2.84 during Monday's after-market session. The market value of their outstanding shares is at $22.9 million.

Via Benzinga

Regulus Moving Closer To Potential $25 Million Milestone Payment For Novel Kidney Disease Treatment Licensed To Sanofi ↗

March 18, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Up to 60,000 people in the US with a rare genetic kidney...

Via Benzinga

Recap: Regulus Therapeutics Q4 Earnings ↗

March 10, 2022

Regulus Therapeutics (NASDAQ:RGLS) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

Regulus Therapeutics's Earnings: A Preview ↗

March 09, 2022

Regulus Therapeutics (NASDAQ:RGLS) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement....

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 02, 2022

Gainers Trevi Therapeutics (NASDAQ:TRVI) shares rose 46.6% to $1.28 during Wednesday's regular session. As of 12:30 EST, Trevi Therapeutics's stock is trading at a...

Via Benzinga

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗

March 06, 2022

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...

Via Benzinga

Executives Buy Over $6M Of 5 Penny Stocks ↗

February 08, 2022

Although gold prices traded slightly lower to below $1,820 an ounce on Tuesday ahead of US inflation data due later in the week, there were a few notable insider trades.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 04, 2022

Gainers Calyxt (NASDAQ:CLXT) shares rose 12.4% to $1.63 during Friday's pre-market session. The company's market cap stands at $62.7 million. Better Therapeutics (...

Via Benzinga

68 Biggest Movers From Yesterday ↗

March 03, 2022

Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to...

Via Benzinga

5 Penny Stocks Insiders Are Buying: OpGen, Regulus Therapeutics And More ↗

January 27, 2022

The US economy grew 6.9% on quarter during the last three months of previous year, up from 2.3% expansion in the prior quarter and also above marke...

Via Benzinga

The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective ↗

January 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kura Announces Lifting Of Clinical Hold On Phase 1 Blood Cancer Study Kura...

Via Benzinga

Regulus Therapeutics Moves Forward With Next-Gen Compound, RGLS8429 In Kidney Disorder ↗

January 21, 2022

Regulus Therapeutics Inc (NASDAQ: RGLS) has completed a pre-investigational new drug (Pre-IND) meeting with the FDA to obtain input on the Company's RGLS8429...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

January 12, 2022

On Wednesday, 41 stocks made new 52-week lows. Facts of Interest About Today's 52-Week Lows: Biogen (NASDAQ:BIIB) was the biggest company by market cap to set a...

Via Benzinga

Stocks Hitting New 52-Week Lows Today ↗

January 03, 2022

On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.